Coloma Jason V sold MAZE
November 2, 2026 · Form 4 insider transaction
Coloma Jason V sold 336 shares of Maze Therapeutics, Inc. at $30.91 per share, a transaction worth $10.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
336
Price
$30.91
Total value
$10.4K
InsiderColoma Jason V
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 2, 2026
Filing dateNovember 4, 2026
Shares owned after12,965
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.805 to $31.70 per share, inclusive.; These securities are directly held by The Coloma 2021 Irrevocable Trust, for which the reporting person and his spouse serve as co-trustees.